Category Archive: Pharmaceutical Litigation

Prescription drugs are meant to help patients recover from or cope with encumbering medical conditions. Unfortunately, not all prescription drugs are made or distributed with patients’ best interests in mind; many cause undue harm, injury, and even death. If you are the victim of a pharmaceutical drug that’s caused you harm that you would not have suffered but for the medication, you have the right to pursue a civil action. At Napoli Shkolnik, PLLC our attorneys can help you to determine who is liable for your injuries, and file a claim to recover damages for economic and noneconomic losses.

1 2 3 4 5 6
Prescription Drug Elmiron May Cause Vision Loss

Prescription Drug Elmiron May Cause Vision Loss

| Pharmaceutical Litigation
A medication that is prescribed to treat various bladder issues has been linked to a rare vision problem known as pigmentary maculopathy, and other conditions which can cause the victim to lose his or her sight. Recent research reports show that condition occurs in patients who have been using Elmiron long-term and is causing vision…Read the article
FDA Demands Zantac Recall

FDA Demands Zantac Recall

| Pharmaceutical Litigation
Recent evidence links the popular heartburn medication to an increased cancer risk, thus FDA demands Zantac recall. The agency wants all ranitidine off store shelves effective immediately. Currently, the Food and Drug Administration is sending letters to Sanofi and other ranitidine manufactures asking them to stop making and shipping product. Additionally, the FDA advises consumers…Read the article
Zantac Injury Attorneys

Zantac Injury Attorneys

| Pharmaceutical Litigation
Over-the-counter Zantac (Ranitidine) is already one of the largest-selling antacids in the United States. Annual revenue exceeds $125 million. That market share was expected to triple by 2026. Then, the Food and Drug Administration found a dangerously-high level of a cancer-causing compound in Zantac. The watchdog then ordered Sanofi to stop selling the drug in…Read the article
Possible FDA Crackdown Against CBD Products

Possible FDA Crackdown Against CBD Products

| Pharmaceutical Litigation
The Food and Drug Administration told over a dozen companies to stop selling cannabidiol-infused food products and stop making inflated health claims about their products. CBD is a non-psychoactive marijuana ingredient which has medicinal properties. Yet the FDA has only approved one CBD product. Epidiolex treats some rare forms of childhood epilepsy. Other CBD products,…Read the article
Major Win for Dangerous Drug Victims

Major Win for Dangerous Drug Victims

| Pharmaceutical Litigation
A Philadelphia jury ordered Johnson & Johnson subsidiary Janssen Pharmaceuticals to pay $8 billion in a drug-induced gynecomastia matter.  26-year-old Nicholas Murray developed abnormally large breasts in 2003. He had been taking Risperdal, an antipsychotic drug, to control his autism spectrum disorder symptoms. In a statement, J&J said it would appeal the “grossly disproportionate” award.…Read the article
Two More Blood Pressure Drugs Added to Ongoing FDA Recall

Two More Blood Pressure Drugs Added to Ongoing FDA Recall

| Pharmaceutical Litigation
The U.S. Food and Drug Administration’s voluntary blood pressure drug recall continues as Torrent Pharmaceuticals Limited announced it is expanding its nationwide recall to include two blood pressure medications that were found to contain trace amounts of a potential cancer-causing carcinogen. The two medications are 3 lots of Losartan Potassium Tablets USP and 2 lots…Read the article
Uloric Lawsuit Claims and Process

Uloric Lawsuit Claims and Process

| Pharmaceutical Litigation
We trust our doctors and trained medical professionals to take care of us and recommended medications that will keep us safe and healthy and that won’t end up causing more harm than good. Unfortunately, more and more often these days, medications are being shown to have known risks and dangers associated with them. Many of…Read the article
Lemtrada Stroke and Arterial Tears Risk

Lemtrada Stroke and Arterial Tears Risk

| Pharmaceutical Litigation
The U.S. Food and Drug Administration (FDA) has put forth an urgent safety alert, in regards to some rare but very life-threatening risks including stroke and artery rupture. The patients at risk are those who have relapsing forms of multiple sclerosis (MS) and are currently being treated with Lemtrada (alemtuzumab). Since Lemtrada’s approval in 2014 to treat relapsing MS, 13 cases worldwide have been…Read the article
Fentanyl Deaths Reach Epidemic Proportions

Fentanyl Deaths Reach Epidemic Proportions

| Pharmaceutical Litigation
The deadliest drug in America does not come from a shady street corner transaction. It’s available at your local pharmacy. Fentanyl just replaced heroin as the deadliest drug in the United States. Between 2013 and 2016, the Fentanyl overdose rate increased over 500 percent. This drug is now responsible for about 16,000 overdose deaths per…Read the article
What Is Taxotere Used For?

What Is Taxotere Used For?

| Pharmaceutical Litigation
If you caught our last article, What You Need to Know About Taxotere, the experienced pharmaceutical litigation team at Napoli Shkolnik PLLC explored what Taxotere is and why it is a dangerous pharmaceutical linked to permanent hair loss in breast cancer survivors treated with this drug. In short, Taxotere is an FDA-approved chemotherapy drug that…Read the article
1 2 3 4 5 6